Latest DEF 14A proxy statements

Scilex Holding Company announces its 2026 Annual Meeting of Stockholders to be held virtually on June 24, 2026.

Playboy, Inc. has scheduled its 2026 Annual Meeting for June 16, 2026, to vote on director elections and a 10 million share increase to its equity incentive plan.

MidCap Financial Investment Corporation announces its 2026 Annual Meeting of Stockholders to be held virtually on June 18, 2026, to vote on director elections and auditor ratification.

Taboola.com Ltd. announces its 2026 Annual General Meeting to vote on director re-elections, executive compensation policies, and auditor reappointment.

AlTi Global, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation.

Semnur Pharmaceuticals, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 25, 2026.

Light & Wonder outlines executive compensation, director elections, and strategic 2028 financial goals following its transition to a sole ASX listing.

Ollie's Bargain Outlet achieved record store openings and exceeded Adjusted EBITDA targets in fiscal 2025, positioning the retailer for long-term expansion toward a 1,300-store goal.

Femasys Inc. has scheduled its 2026 Annual Meeting for June 24 to elect directors, ratify its independent auditor, and provide updates on executive compensation and corporate governance.

AgEagle Aerial Systems Inc. has scheduled its virtual annual meeting for June 15, 2026, to vote on director elections and executive compensation following a year of significantly narrowed losses.

Equus Total Return, Inc. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders scheduled for June 30, 2026.

Intellinetics, Inc. announces its 2026 Annual Meeting of Stockholders to vote on director elections, equity plan amendments, and executive compensation.

StubHub Holdings, Inc. has issued its 2026 proxy statement detailing the upcoming virtual annual meeting, director elections, and executive compensation advisory votes.

Theriva Biologics has scheduled a special meeting for June 5, 2026, to seek stockholder approval for the issuance of shares related to a 2025 private placement warrant exercise.

SAB Biotherapeutics, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 18, 2026.

Amaze Holdings, Inc. will hold its 2026 Annual Meeting to vote on proposals including a new equity plan, convertible note share issuance, and a substantial increase in authorized common stock, all pointing to significant potential dilution.

Lifeway Foods, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and executive compensation proposals.

Biofrontera Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 11, 2026, to vote on director elections, an increase in equity plan shares, and auditor ratification.

Empire Petroleum Corporation announces its 2026 Annual Meeting of Stockholders to be held on June 17, 2026, to vote on director elections, executive compensation, and a new incentive plan.

FGI Industries Ltd. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and auditor ratification.

MiNK Therapeutics announces its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026.

Allogene Therapeutics announces its 2026 Annual Meeting, seeking shareholder approval to double authorized common stock to 800 million shares.

Broadway Financial Corporation has scheduled its 2026 Annual Meeting of Stockholders for June 17, 2026, to conduct routine governance and compensation votes.

Lifeloc Technologies announces its 2026 Annual Meeting of Shareholders to vote on director elections, auditor ratification, and corporate governance amendments.

Agenus Inc. outlines 2025 clinical progress, a strengthened balance sheet, and key equity proposals for the 2026 Annual Meeting.

UroGen Pharma has filed its definitive proxy statement for the 2026 Annual Meeting of Shareholders to be held on June 22, 2026.

TG Therapeutics announces its 2026 Annual Meeting of Stockholders to be held virtually on June 11, 2026.

LandBridge Company LLC has scheduled its 2026 Annual Meeting of shareholders for June 18, 2026, to vote on director elections, auditor ratification, and executive compensation.

Magnachip Semiconductor Corporation has filed its 2026 proxy statement, outlining proposals for the upcoming annual meeting on June 11, 2026.

SCYNEXIS, Inc. announces its 2026 Annual Meeting of Stockholders to vote on director elections, auditor ratification, executive compensation, and significant increases in authorized common stock and equity incentive plan shares.